KUALA LUMPUR: IHH Healthcare Bhd
’s net profit for the monetary yr ended Dec 31, 2021 (FY2021) surged to RM1.86 billion in contrast to RM289 million recorded in monetary yr 2020.
Revenue rose to RM17.13 billion from RM13.40 billion beforehand, the group mentioned in a submitting with Bursa Malaysia right now.
Its managing director and chief government officer Dr Kelvin Loh mentioned the improved efficiency is down to the disciplined execution of the group’s technique, underpinned by the belief tradition constructed with its stakeholders.
“We will proceed to strengthen our belief tradition, enhance regionally, synergise globally and develop progress engines. This is with a transparent aim to improve return on fairness (ROE) together with via our concentrate on rising the laboratory enterprise and setting apart US$100 million for our digital transformation journey.
“All of those efforts might be centred on our true north of caring for sufferers, folks, planet and the general public.
IHH has grown from power to power up to now 10 years, and within the years to come, we intend to present sustainable progress for all,” he mentioned.
Moving ahead, IHH mentioned with the world emerges from the pandemic, there could also be short-term headwinds as COVID-19 providers taper off.
“We are cognisant of rising employees prices and inflationary pressures, however stay disciplined and can proceed our journey of enhancing ROE as normalcy returns. Long time period mega-trends will stay intact and beneficial, business-as-usual will return and we see continued progress,” it mentioned.
The board has declared a primary and ultimate dividend of 6 sen per share, payable on April 29, 2022. Entitlement date is March 31, 2022. – Bernama
